Particularly in NSCLC, SOX proteins exhibit dual regulatory functions: Certain members (SOX2) may promote chemotherapy resistance by maintaining cancer stem cell properties, whereas others (SOX17) serve as tumor suppressors by inhibiting oncogenic signaling pathways (15). Here, SOX2 is linked to non-small cell lung carcinoma.